我院32例万古霉素血药浓度监测结果与临床疗效分析

陈淑敏; 田文园; 张杰; 边萌

doi:10.3969/j.issn.1006-0111.2013.03.012

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

我院32例万古霉素血药浓度监测结果与临床疗效分析

陈淑敏, 田文园, 张杰, 边萌

文章导航 > 药学实践与服务 > 2013 > 31(3): 204-206,209

陈淑敏, 田文园, 张杰, 边萌. 我院32例万古霉素血药浓度监测结果与临床疗效分析[J]. 药学实践与服务, 2013, 31(3): 204-206,209. doi: 10.3969/j.issn.1006-0111.2013.03.012

引用本文:

CHENG Shu-min, TIAN Wen-yuan, ZHANG Jie, BIAN Meng. Clinical effects and blood concentration of vancomycin:32 cases report[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(3): 204-206,209. doi: 10.3969/j.issn.1006-0111.2013.03.012

Citation:

CHENG Shu-min, TIAN Wen-yuan, ZHANG Jie, BIAN Meng. Clinical effects and blood concentration of vancomycin:32 cases report[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(3): 204-206,209. doi: 10.3969/j.issn.1006-0111.2013.03.012

我院32例万古霉素血药浓度监测结果与临床疗效分析

doi: 10.3969/j.issn.1006-0111.2013.03.012

首都医科大学附属复兴医院, 北京 100038

Clinical effects and blood concentration of vancomycin:32 cases report

The Affiliated Fuxing Hospital of Shoudu Medical University, Beijing 100038 China

摘要: 目的评价我院32例患者万古霉素血药浓度监测结果与临床疗效分析,为临床合理用药提供参考。方法对我院2011年12月~2012年4月应用万古霉素并监测血药浓度的32例住院患者的临床资料(基础疾病、细菌学培养结果、用药情况、万古霉素血药谷浓度、疗效、肾功能情况等)进行统计、分析。结果细菌检出率53%,用药指征细菌学符合率31%。应用万古霉素的总有效率为69%,万古霉素血药浓度所测得谷值在10~20 mg/L范围内者占25%,治疗后肾功能异常发生率为13%。结论 32例应用万古霉素患者初次测得其血药浓度谷值在有效范围内的比例偏低,对老年患者需重视其血药浓度监测,并结合临床实际实现个体化给药。
- 万古霉素 /
- 血药浓度监测 /
- 临床疗效
Abstract: Objective To evaluate clinical utilization and blood concentration monitoring of vancomycin in our hospital and offer reference to reasonable clinical use of drugs. Methods The clinical information (primary diseases, bacteriological culture, blood concentration of vancomycin, clinical efficacy, renal function) of 32 inpatients who had been treated with vancomycin and their blood concentrations from Dec. 2011 to Apr. 2012 were analyzed statistically. Results The bacteria detection rate was 53%. The drug indications bacteriology coincidence rate was 31%. The total response rate of vancomycin was 68.75%. The valley values of 25% cases were between 10 mg/L and 20 mg/L. The incidence of renal dysfunction after treatment was 12.5%. Conclusion The valley value of blood concentration of the 32 cases using vancomycin that first measured were less in effective range which should be paid attention to the blood concentration monitoring of agedness patients to achieve an ideal individual administration according to clinical practice.
- vancomycin /
- blood concentration monitoring /
- clinical use of drugs

[1]	黄仲义,肖永红,张菁.万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561.
[2]	刘振声,金大鹏,陈增辉.医院感染管理学[M].北京:军事医学科学出版社,2008:328.
[3]	王爱霞,范洪伟,吕玮,等.桑福德抗微生物治疗指南(新译第41版)2011-2012[M].北京:中国协和医科大学出版社,2011:39.
[4]	Liu C,Bayer A,Cosgrove SE,et al.Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children[J].Clin infect Dis,2011,52(3):e18.
[5]	Rybak M,Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst pharm,2009,66:82.
[6]	Rybak MJ.The pharmacokinetic and pharmacodynamic properties of vancomycin[J].Clin Infect Dis,2006,42(Suppl.1):S35

[1]	黄韵, 张正银, 金英, 郑怡菁, 李铁军, 孙莉莉. 耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分离株耐药性及耐药基因分析 . 药学实践与服务, 2024, 42(10): 439-444. doi: 10.12206/j.issn.2097-2024.202309059
[2]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[3]	崔晓林, 付晓菲, 杜艳红, 刘娟, 朱茜, 刘子祺. 临床药师参与吉瑞替尼致QTc间期延长的病例分析 . 药学实践与服务, 2024, 42(6): 263-266. doi: 10.12206/j.issn.2097-2024.202309050
[4]	杨凤艳, 张月, 陈恩贤, 缪雪蓉, 魏凯. 瑞马唑仑临床应用研究进展 . 药学实践与服务, 2024, 42(9): 365-374. doi: 10.12206/j.issn.2097-2024.202405026
[5]	桂明珠, 李静, 李志玲. 儿童伏立康唑的血药浓度与CYP2C19、CYP2C9和CYP3A5基因多态性的相关性研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202402020
[6]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035

点击查看大图

计量

文章访问数: 3194
HTML全文浏览量: 357
PDF下载量: 93
被引次数: 0

我院32例万古霉素血药浓度监测结果与临床疗效分析

doi: 10.3969/j.issn.1006-0111.2013.03.012

首都医科大学附属复兴医院, 北京 100038

收稿日期: 2012-07-02
修回日期: 2012-09-11

关键词:

万古霉素 /

血药浓度监测 /

临床疗效

摘要: 目的评价我院32例患者万古霉素血药浓度监测结果与临床疗效分析,为临床合理用药提供参考。方法对我院2011年12月~2012年4月应用万古霉素并监测血药浓度的32例住院患者的临床资料(基础疾病、细菌学培养结果、用药情况、万古霉素血药谷浓度、疗效、肾功能情况等)进行统计、分析。结果细菌检出率53%,用药指征细菌学符合率31%。应用万古霉素的总有效率为69%,万古霉素血药浓度所测得谷值在10~20 mg/L范围内者占25%,治疗后肾功能异常发生率为13%。结论 32例应用万古霉素患者初次测得其血药浓度谷值在有效范围内的比例偏低,对老年患者需重视其血药浓度监测,并结合临床实际实现个体化给药。